Enliven Therapeutics Announces New CEO to Drive Next Phase of Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BABA
9. OSIS
10. REAX

Go back to Enliven Therapeutics Announces New CEO to Drive Next Phase of Development
(NASDAQ: ELVN) Delayed: 59.82 +0.90 (1.53%)
Previous Close $58.92    52 Week High $ 
Open $59.00    52 Week Low $ 
Day High $60.00    P/E N/A 
Day Low $58.83    EPS $ 
Volume 596,370